Cargando…
Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer
Prostate cancer (PCa) treatment was first established by Huggins and Hodges in 1941, primarily described as androgen deprivation via interference of testicular androgen production. The disease remains incurable with relapse of hormone-refractory cancer after treatments. Epidemiological and clinical...
Autores principales: | Lau, Kin-Mang, To, Ka-Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037713/ https://www.ncbi.nlm.nih.gov/pubmed/27589731 http://dx.doi.org/10.3390/ijms17091434 |
Ejemplares similares
-
Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer
por: Leung, Yuet-Kin, et al.
Publicado: (2014) -
Correction: Hsa-miRNA-765 as a Key Mediator for Inhibiting Growth, Migration and Invasion in Fulvestrant-Treated Prostate Cancer
por: Leung, Yuet-Kin, et al.
Publicado: (2019) -
Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000) -
Signal Crosstalk and the Role of Estrogen Receptor beta (ERβ) in Prostate Cancer
por: Li, Jialin, et al.
Publicado: (2022) -
Estrogen Receptor Signaling in Breast Cancer
por: Miziak, Paulina, et al.
Publicado: (2023)